Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (i) meet the diagnostic criteria for schizophrenia; (ii) outpatients or inpatients being treated with at least one antipsychotic medication; (iii) have normal intelligence, are capable of completing the assessments, and are able to fully understand the contents of the informed consent form; and (iv) patients whose family members are aware of and agree with the information and voluntarily sign the informed consent form and are willing to cooperate with the study. ? Age 18-60 years old.
Exclusion criteria
Exclusion criteria: Patients who are in the acute phase of schizophrenia; ? patients with other mental illnesses or alcohol or drug dependence, or patients with traumatic brain injury, epilepsy, or serious heart, liver or kidney disease; ? patients who are intellectually challenged or unable to cooperate with the study for other reasons; ? patients who have been treated with long-acting antipsychotics in the past 90 days; ? patients who have received other cognitive-behavioral treatments in the past 90 days; ? females who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Morisky Medication Adherence Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive and Negative Syndrome Scale;Schizophrenia Quality of Life Scale for Patients with Schizophrenia (SQLS);Self-Awareness and Treatment Attitudes Questionnaire; | — |
Countries
China
Contacts
The Sixth Hospital / Institute of Mental Health Peking University